These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 22043204)

  • 1. Role of differential signaling pathways and oxidative stress in diabetic cardiomyopathy.
    Watanabe K; Thandavarayan RA; Harima M; Sari FR; Gurusamy N; Veeraveedu PT; Mito S; Arozal W; Sukumaran V; Laksmanan AP; Soetikno V; Kodama M; Aizawa Y
    Curr Cardiol Rev; 2010 Nov; 6(4):280-90. PubMed ID: 22043204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of 14-3-3 protein and oxidative stress in diabetic cardiomyopathy.
    Watanabe K; Thandavarayan RA; Gurusamy N; Zhang S; Muslin AJ; Suzuki K; Tachikawa H; Kodama M; Aizawa Y
    Acta Physiol Hung; 2009 Sep; 96(3):277-87. PubMed ID: 19706371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetic cardiomyopathy and oxidative stress: role of antioxidants.
    Thandavarayan RA; Giridharan VV; Watanabe K; Konishi T
    Cardiovasc Hematol Agents Med Chem; 2011 Oct; 9(4):225-30. PubMed ID: 21902660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative stress and diabetic cardiomyopathy: a brief review.
    Cai L; Kang YJ
    Cardiovasc Toxicol; 2001; 1(3):181-93. PubMed ID: 12213971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetic Cardiomyopathy: An Update of Mechanisms Contributing to This Clinical Entity.
    Jia G; Hill MA; Sowers JR
    Circ Res; 2018 Feb; 122(4):624-638. PubMed ID: 29449364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose-induced cell signaling in the pathogenesis of diabetic cardiomyopathy.
    Mortuza R; Chakrabarti S
    Heart Fail Rev; 2014 Jan; 19(1):75-86. PubMed ID: 23430126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular endothelial dysfunction in diabetic cardiomyopathy: pathogenesis and potential treatment targets.
    Farhangkhoee H; Khan ZA; Kaur H; Xin X; Chen S; Chakrabarti S
    Pharmacol Ther; 2006 Aug; 111(2):384-99. PubMed ID: 16343639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetic cardiomyopathy: understanding the molecular and cellular basis to progress in diagnosis and treatment.
    Falcão-Pires I; Leite-Moreira AF
    Heart Fail Rev; 2012 May; 17(3):325-44. PubMed ID: 21626163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of ERK1/2 in the Development of Diabetic Cardiomyopathy.
    Xu Z; Sun J; Tong Q; Lin Q; Qian L; Park Y; Zheng Y
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27941647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetic Cardiomyopathy: Current and Future Therapies. Beyond Glycemic Control.
    Borghetti G; von Lewinski D; Eaton DM; Sourij H; Houser SR; Wallner M
    Front Physiol; 2018; 9():1514. PubMed ID: 30425649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabinoid 1 receptor promotes cardiac dysfunction, oxidative stress, inflammation, and fibrosis in diabetic cardiomyopathy.
    Rajesh M; Bátkai S; Kechrid M; Mukhopadhyay P; Lee WS; Horváth B; Holovac E; Cinar R; Liaudet L; Mackie K; Haskó G; Pacher P
    Diabetes; 2012 Mar; 61(3):716-27. PubMed ID: 22315315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of AMP-activated protein kinase on cardio-metabolic abnormalities in the development of diabetic cardiomyopathy: A molecular landscape.
    Haye A; Ansari MA; Rahman SO; Shamsi Y; Ahmed D; Sharma M
    Eur J Pharmacol; 2020 Dec; 888():173376. PubMed ID: 32810493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exercise Amaliorates Metabolic Disturbances and Oxidative Stress in Diabetic Cardiomyopathy: Possible Underlying Mechanisms.
    Mahmoud AM
    Adv Exp Med Biol; 2017; 999():207-230. PubMed ID: 29022265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetic cardiomyopathy revisited.
    Boudina S; Abel ED
    Circulation; 2007 Jun; 115(25):3213-23. PubMed ID: 17592090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diabetic cardiomyopathy--a type of coronary artery disease?].
    Stratmann B; Stork I; Tschoepe D
    Internist (Berl); 2008 Apr; 49(4):436-40. PubMed ID: 18301873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy.
    Rajesh M; Mukhopadhyay P; Bátkai S; Patel V; Saito K; Matsumoto S; Kashiwaya Y; Horváth B; Mukhopadhyay B; Becker L; Haskó G; Liaudet L; Wink DA; Veves A; Mechoulam R; Pacher P
    J Am Coll Cardiol; 2010 Dec; 56(25):2115-25. PubMed ID: 21144973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of hyperglycaemia in the development of diabetic cardiomyopathy.
    El Hayek MS; Ernande L; Benitah JP; Gomez AM; Pereira L
    Arch Cardiovasc Dis; 2021 Nov; 114(11):748-760. PubMed ID: 34627704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diabetic cardiomyopathy].
    Okoshi K; Guimarães JF; Di Muzio BP; Fernandes AA; Okoshi MP
    Arq Bras Endocrinol Metabol; 2007 Mar; 51(2):160-7. PubMed ID: 17505622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The diabetic cardiomyopathy.
    Tarquini R; Lazzeri C; Pala L; Rotella CM; Gensini GF
    Acta Diabetol; 2011 Sep; 48(3):173-81. PubMed ID: 20198391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetic cardiomyopathy: mechanisms and new treatment strategies targeting antioxidant signaling pathways.
    Huynh K; Bernardo BC; McMullen JR; Ritchie RH
    Pharmacol Ther; 2014 Jun; 142(3):375-415. PubMed ID: 24462787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.